|
Coronary artery treated with PCI
| | |
ns
|
|
LM
|
0
|
2
|
|
LAD
|
16
|
19
|
|
Cx
|
8
|
8
|
|
AL
|
0
|
1
|
|
RCA
|
8
|
12
|
|
Number of coronary arteries treated with PCI
| | |
ns
|
|
single-vessel PCI
|
17
|
18
|
|
dual-vessel PCI
|
6
|
9
|
|
triple-vessel PCI
|
1
|
2
|
|
Number of lesions treated with PCI
| | |
ns
|
|
single-lesion PCI
|
13
|
14
|
|
dual-lesion PCI
|
9
|
12
|
|
triple-lesion PCI
|
2
|
1
|
|
Type of lesion treated with PCI according to the ACC/AHA classification
| | |
ns
|
|
B1
|
11
|
7
|
|
B2
|
11
|
9
|
|
C
|
15
|
25
|
|
Baseline flow in the culprit artery
| | |
ns
|
|
TIMI 0 or 1
|
15
|
20
|
|
TIMI 2
|
1
|
1
|
|
TIMI 3
|
8
|
7
|
|
Final flow in the culprit artery
| | |
ns
|
|
TIMI 0
|
0
|
1
|
|
TIMI 3
|
24
|
26
|
|
Number of stents implanted for patient
| | |
ns
|
|
0
|
0
|
2 #
|
|
1
|
10
|
12
|
|
2
|
8
|
8
|
|
3 or more
|
5
|
5
|
|
Type of implanted stent
| | |
ns
|
|
bare metal stent
|
42
|
48
|
|
drug-eluting stent
|
1
|
0
|
|
Total length of implanted stents per patient [mm]
|
33 (15–44)
|
33 (16–50)
|
ns
|
|
Diameter of implanted stent [mm]
|
3.3 (2.8-3.5)
|
3.0 (2.8-3.4)
|
ns
|
|
Therapy with abciximab
|
5 (20.8%)
|
5 (18.5%)
|
ns
|
|
Application of thrombectomy
|
6/24
|
3/27
|
ns
|
|
Door-to-balloon time * [minutes]
|
40.5 (31.5-68.5)
|
70.0 (32.0-81.0)
|
ns
|
|
Direct effect of PCI in the culprit lesion
| | |
ns
|
|
optimal
|
23
|
25
|
|
suboptimal
|
1
|
1
|
|
ineffective
|
0
|
1
| |
